Bangladesh has signed a memorandum of understanding (MoU) with the Serum Institute of India for getting 3 crore doses of Oxford-AtraZeneca's coronavirus vaccine 

Under the agreement, Serum Institute will provide the Oxford-AtraZeneca's vaccine to Beximco Pharmaceuticals of Bangladesh.

Representatives of Serum and Beximco signed the MoU in presence of Health Minister Zahid Maleque and Indian High Commissioner Vikram K Doraiswami at the health ministry's conference room in Dhaka on Thursday afternoon.

According to the deal, Serum will supply three crore doses of the vaccine – 50 lakh per month – to Bangladesh at a price similar to what India will get at, once it is finally approved for human application.

The government will procure this Covid-19 vaccine via the local drug producer, Beximco Pharmaceuticals, the sole supplier of Seram's vaccine to Bangladesh.

Earlier, the Health Service Division sent a proposal to the Prime Minister's Office for approval to import Serum's vaccine through Beximco.

BDST: 1440 HRS, NOV 05, 2020
AP/SMS